Identification of the differential expression of serum microRNA in type 2 diabetes

References

• Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res. Clin. Pract. 2011;94:311–321.
   PubMed Web of Science ®Google Scholar
• Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813–820.
   PubMed Web of Science ®Google Scholar
• Rhodes CJ. Type 2 diabetes-a matter of beta-cell life and death? Science. 2005;307:380–384.
   PubMed Web of Science ®Google Scholar
• Weir GC, Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes. 2004;53:S16–S21.
   PubMed Web of Science ®Google Scholar
• Wadwa RP, Jaiswal M. Vascular measures to detect earlier macrovascular disease. Diabetes Technol. Ther. 2011;13:1269–1270.
   PubMed Web of Science ®Google Scholar
• Guay C, Regazzi R. Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat. Rev. Endocrinol. 2013;9:513–521.
   PubMed Web of Science ®Google Scholar
• Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. Jama. 2003;289:76–79.
   PubMed Web of Science ®Google Scholar
• Guo L, Jiang F, Tang YT, et al. The Association of serum vascular endothelial growth factor and ferritin in diabetic microvascular disease. Diabetes Technol. Ther. 2014;16:224–234.
   PubMed Web of Science ®Google Scholar
• Li R, Zhang P, Barker LE, et al. Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care. 2010;33:1872–1894.
   PubMed Web of Science ®Google Scholar
• Stark A, Brennecke J, Bushati N, et al. Animal microRNAs confer robustness to gene expression and have a significant impact on 3’UTR evolution. Cell. 2005;123:1133–1146.
   PubMed Web of Science ®Google Scholar
• Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev. Cell. 2006;11:441–450.
   PubMed Web of Science ®Google Scholar
• Lee RC, Feinbaum RL, Ambros V, et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843–854.
   PubMed Web of Science ®Google Scholar
• Chin LJ, Slack FJ. A truth serum for cancer–microRNAs have major potential as cancer biomarkers. Cell Res. 2008;18:983–984.
   PubMed Web of Science ®Google Scholar
• Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18:997–1006.
   PubMed Web of Science ®Google Scholar
• Ajit SK. Circulating microRNAs as biomarkers, therapeutic targets, and signaling molecules. Sensors. 2012;12:3359–3369.
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. PNAS. 2008;105:10513–10518.
   PubMed Web of Science ®Google Scholar
• Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. PNAS. 2011;108:5003–5008.
   PubMed Web of Science ®Google Scholar
• Hunter MP, Ismail N, Zhang X, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE. 2008;3:e3694.
   PubMed Web of Science ®Google Scholar
• Gibbings DJ, Ciaudo C, Erhardt M, et al. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat. Cell Bio. 2009;11:1143–1149.
   PubMed Web of Science ®Google Scholar
• Etheridge A, Lee I, Hood L, et al. Extracellular microRNA: a new source of biomarkers. Mutat. Res-Fund Mol. M. 2011;717:85–90.
   PubMed Web of Science ®Google Scholar
• Zhu W, Qin W, Atasoy U, et al. Circulating microRNAs in breast cancer and healthy subjects. BMC Res. Notes. 2009;2:89. doi: 10.1186/1756-0500-2-89.
   PubMedGoogle Scholar
• Lawrie CH, Gal S, Dunlop HM, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. PNAS. 2009;106:4402–4407.
   PubMed Web of Science ®Google Scholar
• Ng EK, Chong WW, Jin H, et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut. 2009;58:1375–1381.
   PubMed Web of Science ®Google Scholar
• Wang JF, Yu ML, Yu G, et al. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem. Biophys. Res. Co. 2010;394:184–188.
   PubMed Web of Science ®Google Scholar
• Laterza OF, Lim L, Garrett-Engele PW, et al. Plasma microRNAs as sensitive and specific biomarkers of tissue injury. Clin. Chem. 2009;55:1977–1983.
   PubMed Web of Science ®Google Scholar
• Whitehead CL, Teh WT, Walker SP, et al. Circulating microRNAs in maternal blood as potential biomarkers for fetal hypoxia in-utero. PLoS ONE. 2013;8:e78487.
   PubMed Web of Science ®Google Scholar
• Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ. Res. 2012;110:483–495.
   PubMed Web of Science ®Google Scholar
• Jima DD, Zhang J, Jacobs C, et al. Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood. 2010;116:e118–e127.
   PubMed Web of Science ®Google Scholar
• Hie M, Tsukamoto I. Increased expression of the receptor for activation of NF-κB and decreased runt-related transcription factor 2 expression in bone of rats with streptozotocin-induced diabetes. Int. J. Mol. Med. 2010;26:611–618.
   PubMed Web of Science ®Google Scholar
• Hu R, Liu W, Li H, et al. A Runx2/miR-3960/miR-2861 regulatory feedback loop during mouse osteoblast differentiation. J. Biol. Chem. 2011;286:12328–12339.
   PubMed Web of Science ®Google Scholar
• Murata K, Yoshitomi H, Furu M, et al. MicroRNA-451 down-regulates neutrophil chemotaxis via p38 MAPK. Arthritis Rheumatol. 2014;66:549–559.
   PubMed Web of Science ®Google Scholar
• Lim A, Nikolic-Paterson D, Ma F, et al. Role of MKK3–p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice. Diabetologia. 2009;52:347–358.
   PubMed Web of Science ®Google Scholar
• Zhang H, Li W, Nan F, et al. MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line. Biochem. Biol. Res. Co. 2011;404:273–278.
   PubMed Web of Science ®Google Scholar
• Cummins JM, He Y, Leary RJ, et al. The colorectal microRNAome. PNAS. 2006;103:3687–3692.
   PubMed Web of Science ®Google Scholar